Is tissue still the issue in detecting molecular alterations in lung cancer?

ABSTRACT Molecular biomarker testing of advanced‐stage NSCLC is now considered standard of care and part of the diagnostic algorithm to identify subsets of patients for molecular‐targeted treatment. Tumour tissue biopsy is essential for an accurate initial diagnosis, determination of the histologica...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Respirology (Carlton, Vic.) Vic.), 2020-09, Vol.25 (9), p.933-943
Hauptverfasser:	Liam, Chong‐Kin, Mallawathantri, Sugamya, Fong, Kwun M.
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomarkers Biopsy Diagnosis Disease resistance Genomes liquid biopsy Lung cancer molecular testing Non-small cell lung carcinoma Respiratory diseases targeted therapy Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!